Despite continuing market volatility, the S&P 500 has remained relatively flat in 2020 – down just 1.66%.
But there is a silver lining…
Many of you know Marc Lichtenfeld as the “income guy” because of his work with The Oxford Income Letter…
But he’s as passionate about biotech investing as he is about dividends.
In fact, he’s been tracking the sector for several decades now and has spoken about biotech opportunities at events all over the world.
Last year, Marc hosted a summit with former Speaker of the House Newt Gingrich to uncover the opportunities within the gene therapy subsector of biotech.
Since then, gene therapy companies are up nearly 40%. (Compare that with the measly returns of the S&P!)
It’s clear that Marc has a knack for finding biotech stocks that are poised to take off – just ask his subscribers who landed 2,381% gains on his recent recommendation!
So, in Marc’s latest State of the Market video, he addresses a common question from readers…
“What do you look for when you invest in biotech companies?”
In the short video, Marc outlines the five specific qualifications he looks for before recommending a biotech company.